CIK 0001757073 · Large accelerated filer
Envista Holdings Corp
Sign in to watch- Ticker
- NVST
- Exchange
- NYSE
- Industry
- Dental Equipment & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832206728
- Phone
- 714-817-5418
- Business address
- 200 S. KRAEMER BLVD., BLDG. E, BREA, CA, 92821
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $220,000
- in 1 filing, $220K under 10b5-1 plans
Net −$220,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-25 | Reis Mischa SVP, Strategy & Bus. Dev. | Grant or award · Performance Share Unit | +15,615 | 15,615 | ||
| 2025-02-25 | Reis Mischa SVP, Strategy & Bus. Dev. | Grant or award · Employee Stock Option (Right to Buy) | +19,780 | 19,780 | ||
| 2025-02-25 | Keel Paul A Chief Executive Officer | Grant or award | +65,830 | 414,439 | ||
| 2025-02-25 | Keel Paul A Chief Executive Officer | Grant or award · Performance Share Unit | +181,985 | 181,985 | ||
| 2025-02-25 | Keel Paul A Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +153,660 | 153,660 | ||
| 2025-02-25 | Acurio Veronica President, Orthodontics | Grant or award | +10,290 | 55,745 | ||
| 2025-02-25 | Acurio Veronica President, Orthodontics | Grant or award · Performance Share Unit | +18,960 | 18,960 | ||
| 2025-02-25 | Acurio Veronica President, Orthodontics | Grant or award · Employee Stock Option (Right to Buy) | +24,010 | 24,010 | ||
| 2025-02-25 | Nilsson Stefan President, Nobel Biocare | Grant or award | +10,290 | 55,745 | ||
| 2025-02-25 | Nilsson Stefan President, Nobel Biocare | Grant or award · Performance Share Unit | +18,960 | 18,960 | ||
| 2025-02-25 | Nilsson Stefan President, Nobel Biocare | Grant or award · Employee Stock Option (Right to Buy) | +24,010 | 24,010 | ||
| 2025-02-25 | Befidi Robert President, Diagnostics | Shares withheld for taxes | −1,123 | $20.66 | $23K | 38,668 |
| 2025-02-25 | Befidi Robert President, Diagnostics | Grant or award | +10,290 | 48,958 | ||
| 2025-02-25 | Befidi Robert President, Diagnostics | Grant or award · Performance Share Unit | +18,960 | 18,960 | ||
| 2025-02-25 | Befidi Robert President, Diagnostics | Grant or award · Employee Stock Option (Right to Buy) | +24,010 | 24,010 | ||
| 2025-02-25 | Hammes Eric D. Chief Financial Officer | Grant or award | +15,735 | 104,442 | ||
| 2025-02-25 | Hammes Eric D. Chief Financial Officer | Grant or award · Performance Share Unit | +28,995 | 28,995 | ||
| 2025-02-25 | Hammes Eric D. Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +36,720 | 36,720 | ||
| 2025-02-25 | Nance Mark E General Counsel | Shares withheld for taxes | −3,691 | $20.66 | $76K | 53,790 |
| 2025-02-25 | Nance Mark E General Counsel | Grant or award | +18,155 | 71,945 |
Page 5 of 9 · 175 trades